Insider · CIK 0001244229

NELSON TIMOTHY S

Reports to the SEC for 4 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001244229

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-04-05	IPI Legacy Liquidation CoJ Other	Director	JOther	−10K sh	—	—	0
2024-04-05	IPI Legacy Liquidation CoStock Option (right to buy)J Other	Director	JOther	−12.3K sh	—	—	0
2024-04-05	IPI Legacy Liquidation CoStock Option (right to buy)J Other	Director	JOther	−3,053 sh	—	—	0
2024-04-05	IPI Legacy Liquidation CoStock Option (right to buy)J Other	Director	JOther	−22.3K sh	—	—	0
2024-04-05	IPI Legacy Liquidation CoStock Option (right to buy)J Other	Director	JOther	−11.5K sh	—	—	0
2024-04-05	IPI Legacy Liquidation CoStock Option (right to buy)J Other	Director	JOther	−12.8K sh	—	—	0
2024-04-05	IPI Legacy Liquidation CoStock Option (right to buy)J Other	Director	JOther	−13.2K sh	—	—	0
2023-06-16	IPI Legacy Liquidation CoStock Option (right to buy)A Award	Director	AAward	+13.2K sh	—	—	13,222
2022-06-16	IPI Legacy Liquidation CoStock Option (right to buy)A Award	Director	AAward	+12.8K sh	—	—	12,789
2021-11-19	IPI Legacy Liquidation CoP Purchase	Director	PPurchase	+10K sh	$10.76	+$108K	10,000
2021-07-11	IPI Legacy Liquidation CoStock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,500
2014-12-03	SRDXSURMODICS INCA Award	Director	AAward	+1,118 sh	—	—	6,176
2014-12-03	SRDXSURMODICS INC · Employee Stock Option (right to buy)A Award	Director	AAward	+4,430 sh	—	—	4,430
2014-02-17	SRDXSURMODICS INCA Award	Director	AAward	+1,217 sh	—	—	5,058
2014-02-17	SRDXSURMODICS INC · Stock Option (right to buy)A Award	Director	AAward	+4,098 sh	—	—	4,098
2013-03-01	MAP Pharmaceuticals, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−38.7K sh	$25.00	−$969K	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−133K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−71.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−179K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−121K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−181K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−160K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−175K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−100K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−200K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−113K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−28.1K sh	—	—	0
2013-01-25	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+9,375 sh	—	—	42,392
2013-01-25	MAP Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−3,652 sh	$24.75	−$90.4K	38,740
2013-01-25	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−9,375 sh	—	—	28,125
2013-01-23	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+80K sh	$0.64	+$51.2K	113,017
2013-01-23	MAP Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−80K sh	$24.76	−$1.98M	33,017
2013-01-23	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−80K sh	—	—	132,549
2012-11-20	MAP Pharmaceuticals, Inc.J Other	Director, President and CEO	JOther	+1,297 sh	$9.89	+$12.8K	33,017
2012-01-25	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+113K sh	—	—	112,500
2012-01-25	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)A Award	Director, President and CEO	AAward	+37.5K sh	—	—	37,500
2011-12-21	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+6,638 sh	$0.64	+$4,255.622	37,906
2011-12-21	MAP Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−6,638 sh	$14.52	−$96.4K	31,268
2011-12-21	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−6,638 sh	—	—	212,549
2011-12-20	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+13.4K sh	$0.64	+$8,566.378	44,630
2011-12-20	MAP Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−13.4K sh	$14.50	−$194K	31,268
2011-12-20	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−13.4K sh	—	—	219,187
2011-08-04	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+10K sh	—	—	34,937
2011-08-04	MAP Pharmaceuticals, Inc.F Tax Payment	Director, President and CEO	FTax Payment	−3,669 sh	$13.43	−$49.3K	31,268
2011-08-04	MAP Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−10K sh	—	—	6,331
2011-05-20	MAP Pharmaceuticals, Inc.J Other	Director, President and CEO	JOther	+452 sh	$12.65	+$5,716.896	31,720
2011-01-26	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director, President and CEO	AAward	+200K sh	—	—	200,000
2010-11-20	MAP Pharmaceuticals, Inc.J Other	Director, President and CEO	JOther	+378 sh	$12.49	+$4,723.11	24,937
2010-07-01	MAP Pharmaceuticals, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+15K sh	$0.64	+$9,616.5	38,963
2010-07-01	MAP Pharmaceuticals, Inc.S Sale	Director, President and CEO	SSale	−15K sh	$12.15	−$182K	23,963

Recent filings

Accepted (ET)
Apr 94
NELSON TIMOTHY S0001415889-24-010567
SEC(opens sec.gov)
Jun 204
NELSON TIMOTHY S0001209191-23-038599
SEC(opens sec.gov)
Jun 174
NELSON TIMOTHY S0001209191-22-037953
SEC(opens sec.gov)
Nov 224
NELSON TIMOTHY S0001209191-21-066134
SEC(opens sec.gov)
Jul 134
NELSON TIMOTHY S0001209191-21-046564
SEC(opens sec.gov)
Dec 54
SURMODICS INC0001209191-14-073361
SEC(opens sec.gov)
Feb 194
SURMODICS INC0001209191-14-011917
SEC(opens sec.gov)
Mar 44
NELSON TIMOTHY S0001181431-13-014242
SEC(opens sec.gov)

Companies

Address

C/O MAP PHARMACEUTICALS, INC. 2400 BAYSHORE PARKWAY, SUITE 200

MOUNTAIN VIEW, CA, 94043